Systemic lupus erythematosus and Sjögren's syndrome induced in a case by interferon-α used for the treatment of hepatitis C
Authors:
- 11 January 2010
- journal article
- case report
- Published by SAGE Publications in Lupus
- Vol. 19 (6) , 753-755
Abstract
A 57-year-old Japanese woman developed skin eruption, pleuritis, pancytopenia, parotid gland swelling and glomerulonephritis after 7-month treatment with pegylated interferon-α and ribavirin for chronic hepatitis C. Disease-specific autoantibodies such as anti-SSA, anti-SSB, anti-Sm and anti-dsDNA antibodies became positive. The diagnosis of systemic lupus erythematosus and Sjögren’s syndrome was made and treatment with glucocorticoid pulse followed by oral glucocorticoid was started. It is highly probable that interferon-α-induced systemic lupus erythematosus and Sjögren’s syndrome in this case. Interferon-α might be important pathogenically in these diseases. Lupus (2010) 19, 753—755.Keywords
This publication has 8 references indexed in Scilit:
- Severe Systemic Lupus Erythematosus Induced by Antiviral Treatment for Hepatitis CJCR: Journal of Clinical Rheumatology, 2008
- Activation of the type I interferon system in primary Sjögren's syndrome: A possible etiopathogenic mechanismArthritis & Rheumatism, 2005
- Autoimmune disease complicating antiviral therapy for hepatitis C virus infectionSeminars in Arthritis and Rheumatism, 2002
- Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus ErythematosusScience, 2001
- Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infectionAnnals of the Rheumatic Diseases, 1998
- Chronic lymphocytic sialoadenitis in HCV‐related chronic liver disease: comparison with Sjögren's syndromeHistopathology, 1997
- New Inuyama classification; new criteria for histological assessment of chronic hepatitisInternational Hepatology Communications, 1996
- Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus InfectionNew England Journal of Medicine, 1993